鄰近類別 會議論文/會議摘要 [27/39] 專利 [0/58] 類別統計 近3年內發表的文件:3(2.08%) 含全文筆數:143(99.31%) 文件下載次數統計 下載大於0次:143(100.00%) 下載大於100次:142(99.30%) 檔案下載總次數:90631(84.39%) 最後更新時間: 2025-04-18 17:03 上傳排行 資料載入中..... 下載排行 資料載入中..... 最近上傳 Development of a humanized antibody... Reducing brain Abeta burden amelior... Development of furanopyrimidine-bas... Targeting the phosphatidylserine-im... Synthesis and evaluation of small m... Extracellular HSP90alpha induces My... The beneficial effects of combining... Acyl-coenzyme a synthetase long-cha... Colloidal assemblies composed of po... The effects of Abeta1-42 binding to...

跳至: (選擇年份) 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 1994 1993 1992 1991 1990 1985 1980 1975 1970 1960 1950 (選擇月份) January February March April May June July August September October November December 或輸入年份:

由新到舊排序 由最舊的開始

顯示項目1-25 / 144. (共6頁) 1 2 3 4 5 6 > >> 每頁顯示[10|25|50]項目

日期	題名	關聯
2024-07-04	Development of a humanized antibody targeting extracellular HSP90alpha to suppress endothelial-mesenchymal transition-enhanced tumor growth of pancreatic adenocarcinoma cells	Cells. 2024 Jul 04;13(13):Article number 1146.
2024-04	Reducing brain Abeta burden ameliorates high-fat diet-induced fatty liver disease in APP/PS1 mice	Biomedicine and Pharmacotherapy. 2024 Apr;173:Article number 116404.
2023-02-07	Development of furanopyrimidine-based orally active third-generation EGFR inhibitors for the treatment of non-small cell lung cancer	Journal of Medicinal Chemistry. 2023 Feb 7;66(4):2566-2588.
2022-10-13	Targeting the phosphatidylserine-immune checkpoint with a small-molecule maytansinoid conjugate	Journal of Medicinal Chemistry. 2022 Oct 13;65(19):12802-12824.
2022-06-21	Synthesis and evaluation of small molecule drug conjugates harnessing thioester-linked maytansinoids	Pharmaceutics. 2022 Jun 21;14(7):Article number 1316.
2022-01-18	Acyl-coenzyme a synthetase long-chain family member 4 is involved in viral replication organelle formation and facilitates virus replication via ferroptosis	mBio. 2022 Jan 18;13(1):Article number e0271721.
2022-01-11	Extracellular HSP90alpha induces MyD88-IRAK complex-associated IKKalpha/Beta−NF-KappaB/IRF3 and JAK2/TYK2−STAT-3 signaling in macrophages for tumor-promoting M2-polarization	Cells. 2022 Jan 11;11(2):Article number 229.
2022-01-05	The beneficial effects of combining anti-Abeta antibody NP106 and curcumin analog TML-6 on the treatment of Alzheimer’s disease in APP/PS1 mice	International Journal of Molecular Sciences. 2022 Jan 5;23(1):Article number 556.
2021-07-30	The effects of Abeta1-42 binding to the SARS-CoV-2 spike protein S1 subunit and angiotensin-converting enzyme 2	International Journal of Molecular Sciences. 2021 Jul 30;22(15):Article number 8226.
2021-07-16	Colloidal assemblies composed of polymeric micellar/emulsified systems integrate cancer therapy combining a tumor-associated antigen vaccine and chemotherapeutic regimens	Nanomaterials. 2021 Jul 16;11(7):Article number 1844.
2021-01	Effect of a neuropilin-1-derived virus receptor trap on enterovirus A71 infection in vitro	Antimicrobial Agents and Chemotherapy. 2021 Jan;65(1):Article number e00695-20.
2020-12	Engineering a novel IgG-like bispecific antibody against enterovirus A71	Biochemistry and Biophysics Reports. 2020 Dec;24:Article number 100860.
2020-08-20	Discovery of M protease inhibitors encoded by SARS-CoV-2	Antimicrobial Agents and Chemotherapy. 2020 Aug 20;64(9):e00872-20.
2020-08	Artificial intelligence approach fighting COVID-19 with repurposing drugs	Biomedical Journal. 2020 Aug;43(4):355-362.
2020-08	Repurposing old drugs as antiviral agents for coronaviruses	Biomedical Journal. 2020 Aug;43(4):368-374.
2020-06-02	Zika virus NS3 protease pharmacophore anchor model and drug discovery	Scientific Reports. 2020 Jun 2;10:Article number 8929.
2020-05	Antiviral activity of llama-inspired single domain antibody against Enterovirus A71	Antimicrobial Agents and Chemotherapy. 2020 May;64(5):Article number e01922-19.
2020-05	Drug-like property optimization: Discovery of orally bioavailable quinazoline-based multi-targeted kinase inhibitors	Bioorganic Chemistry. 2020 May;98:Article number 103689.
2020-04	BPR1M97, a dual mu opioid receptor/nociceptin-orphanin FQ peptide receptor agonist, produces potent antinociceptive effects with safer properties than morphine	Neuropharmacology. 2020 Apr;166:Article number 107678.
2019-11-27	Discovery of a furanopyrimidine-based epidermal growth factor receptor inhibitor (DBPR112) as a clinical candidate for the treatment of non-small cell lung cancer	Journal of Medicinal Chemistry. 2019 Nov 27;62(22):10108-10123.
2019-07-11	Linker optimization and therapeutic evaluation of phosphatidylserine-targeting zinc dipicolylamine-based drug conjugates	Journal of Medicinal Chemistry. 2019 Jul 11;62(13):6047-6062.
2019-05-28	Identification of novel anti-liver cancer small molecules with better therapeutic index than sorafenib via zebrafish drug screening platform	Cancers. 2019 May 28;11(6):Article number 739.
2019-04-01	A novel, potent, and orally bioavailable thiazole HCV NS5A inhibitor for the treatment of hepatitis C virus	European Journal of Medicinal Chemistry. 2019 Apr 1;167:245-268.
2019-02-20	Convallatoxin enhance the ligand-induced mu-opioid receptor endocytosis and attenuate morphine antinociceptive tolerance in mice	Scientific Reports. 2019 Feb 20;9:Article number 2405.
2018-10	Identification of novel Cdc7 kinase inhibitors as anti-cancer agents that target the interaction with Dbf4 by the fragment complementation and drug repositioning approach	EBioMedicine. 2018 Oct;36:241-251.

顯示項目1-25 / 144. (共6頁) 1 2 3 4 5 6 > >> 每頁顯示[10|25|50]項目